Skip to Content


Lifera is a new biopharmaceutical company, wholly owned by the Public Investment Fund (PIF).  We are dedicated to advancing Saudi Arabia’s biopharmaceutical sector and building national health resilience.  Lifera aims to become a leading biopharma Contract Development and Manufacturing Organization (CDMO), ensuring Saudi Arabia achieves biopharma resilience and a thriving biotech sector.  We thrive to build local manufacturing capacity for vaccines, insulin, plasma therapeutics and other biologics, and investing in genetic testing and precision medicine.


  • Build capacity for Chemistry, Manufacturing, and Controls (CMC) & biomanufacturing at scale.
  • Serve customers and build reputation for reliable service.
  • Anchor in KSA and expand globally.
  • Generate insights through Omics.